Medicare Advantage Companies Spend $330M+ To Influence Policy - Public Citizen

WASHINGTON, D.C. — Ahead of Friday’s Senate confirmation hearing for Dr. Mehmet Oz to lead the Centers for Medicare and Medicaid (CMS), Public Citizen released a new research brief shining a light on the hundreds of millions of dollars Medicare Advantage companies have spent on lobbying.

“If Oz is confirmed as the CMS Administrator, attacks on traditional Medicare are likely to move into overdrive,” said Eagan Kemp, a health care policy advocate at Public Citizen. “We should strengthen Medicare by improving it and expanding access to it, not weaken it through further privatization.”

Top findings from the brief include:

https://www.citizen.org/news/medicare-advantage-companies-spend-330m-to-influence-policy/